{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T18:55:40Z","timestamp":1789757740975,"version":"4.0.1"},"reference-count":111,"publisher":"Oxford University Press (OUP)","issue":"suppl_3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,8,15]]},"DOI":"10.1093\/infdis\/jix210","type":"journal-article","created":{"date-parts":[[2017,5,2]],"date-time":"2017-05-02T09:20:30Z","timestamp":1493716830000},"page":"S436-S444","source":"Crossref","is-referenced-by-count":244,"title":["Azole-Resistant Aspergillosis: Epidemiology, Molecular Mechanisms, and Treatment"],"prefix":"10.1093","volume":"216","author":[{"given":"Anuradha","family":"Chowdhary","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheshta","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques F","family":"Meis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,9,5]]},"reference":[{"key":"key\n\t\t\t\t20170906122423_CIT0001","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1136\/thoraxjnl-2014-206291","article-title":"The clinical spectrum of pulmonary aspergillosis","volume":"70","year":"2015","journal-title":"Thorax"},{"key":"key\n\t\t\t\t20170906122423_CIT0002","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1183\/13993003.00583-2015","article-title":"Chronic pulmonary aspergillosis: rationale and clinical guidelines for diagnosis and management","volume":"47","author":"European Society for Clinical Microbiology and Infectious Diseases and European Respiratory Society","year":"2016","journal-title":"Eur Respir J"},{"key":"key\n\t\t\t\t20170906122423_CIT0003","doi-asserted-by":"crossref","first-page":"361","DOI":"10.3109\/13693786.2012.738312","article-title":"Global burden of allergic bronchopulmonary aspergillosis with asthma and its complication chronic pulmonary aspergillosis in adults","volume":"51","year":"2013","journal-title":"Med Mycol"},{"key":"key\n\t\t\t\t20170906122423_CIT0004","first-page":"1149","article-title":"Population-based analysis of invasive fungal infections, France, 2001\u20132010","volume":"20","year":"2014","journal-title":"Emerg Infect Dis"},{"key":"key\n\t\t\t\t20170906122423_CIT0005","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.drup.2015.08.001","article-title":"International expert opinion on the management of infection caused by azole-resistant Aspergillus fumigatus","volume":"21-22","year":"2015","journal-title":"Drug Resist Updat"},{"key":"key\n\t\t\t\t20170906122423_CIT0006"},{"key":"key\n\t\t\t\t20170906122423_CIT0007"},{"key":"key\n\t\t\t\t20170906122423_CIT0008","doi-asserted-by":"crossref","first-page":"6872","DOI":"10.1128\/AAC.00701-16","article-title":"Preclinical evaluation of the stability, safety, and efficacy of CD101, a novel echinocandin","volume":"60","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170906122423_CIT0009","doi-asserted-by":"crossref","first-page":"4053","DOI":"10.1128\/AEM.00231-09","article-title":"Possible environmental origin of resistance of Aspergillus fumigatus to medical triazoles","volume":"75","year":"2009","journal-title":"Appl Environ Microbiol"},{"key":"key\n\t\t\t\t20170906122423_CIT0010","article-title":"Intercountry transfer of triazole-resistant Aspergillus fumigatus on plant bulbs","year":"2017","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170906122423_CIT0011","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1093\/cid\/civ885","article-title":"Azole resistance in Aspergillus fumigatus: can we retain the clinical use of mold-active antifungal azoles?","volume":"62","year":"2016","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170906122423_CIT0012","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1093\/cid\/civ571","article-title":"Isavuconazole: a new broad-spectrum triazole antifungal agent","volume":"61","year":"2015","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170906122423_CIT0013","doi-asserted-by":"crossref","first-page":"697","DOI":"10.2217\/fmb.14.27","article-title":"Exploring azole antifungal drug resistance in Aspergillus fumigatus with special reference to resistance mechanisms","volume":"9","year":"2014","journal-title":"Future Microbiol"},{"key":"key\n\t\t\t\t20170906122423_CIT0014","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1056\/NEJMc061720","article-title":"Multiple-triazole-resistant aspergillosis","volume":"356","year":"2007","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170906122423_CIT0015","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1128\/AAC.01092-06","article-title":"A new Aspergillus fumigatus resistance mechanism conferring in vitro cross-resistance to azole antifungals involves a combination of cyp51A alterations","volume":"51","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170906122423_CIT0016","doi-asserted-by":"crossref","first-page":"e1003633","DOI":"10.1371\/journal.ppat.1003633","article-title":"Emergence of azole-resistant Aspergillus fumigatus strains due to agricultural azole use creates an increasing threat to human health","volume":"9","year":"2013","journal-title":"PLoS Pathog"},{"key":"key\n\t\t\t\t20170906122423_CIT0017","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1093\/cid\/cit320","article-title":"Aspergillosis due to voriconazole highly resistant Aspergillus fumigatus and recovery of genetically related resistant isolates from domiciles","volume":"57","year":"2013","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170906122423_CIT0018","doi-asserted-by":"crossref","first-page":"e31801","DOI":"10.1371\/journal.pone.0031801","article-title":"Triazole fungicides can induce cross-resistance to medical triazoles in Aspergillus fumigatus","volume":"7","year":"2012","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20170906122423_CIT0019","doi-asserted-by":"crossref","first-page":"45631","DOI":"10.1038\/srep45631","article-title":"Azole-resistant Aspergillus fumigatus harboring TR34\/L98H, TR46\/Y121F\/T289A and TR53 mutations related to flower fields in Colombia","volume":"7","year":"2017","journal-title":"Sci Rep"},{"key":"key\n\t\t\t\t20170906122423_CIT0020","doi-asserted-by":"crossref","first-page":"e219","DOI":"10.1371\/journal.pmed.0050219","article-title":"Emergence of azole resistance in Aspergillus fumigatus and spread of a single resistance mechanism","volume":"5","year":"2008","journal-title":"PLoS Med"},{"key":"key\n\t\t\t\t20170906122423_CIT0021","doi-asserted-by":"crossref","first-page":"e251","DOI":"10.1016\/S1473-3099(16)30138-4","article-title":"In-host adaptation and acquired triazole resistance in Aspergillus fumigatus: a dilemma for clinical management","volume":"16","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"key\n\t\t\t\t20170906122423_CIT0022","doi-asserted-by":"crossref","first-page":"e52871","DOI":"10.1371\/journal.pone.0052871","article-title":"Clonal expansion and emergence of environmental multiple-triazole-resistant Aspergillus fumigatus strains carrying the TR\u2083\u2084\/L98H mutations in the cyp51A gene in India","volume":"7","year":"2012","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20170906122423_CIT0023","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.3201\/eid1710.110226","article-title":"Clinical implications of azole resistance in Aspergillus fumigatus, the Netherlands, 2007\u20132009","volume":"17","year":"2011","journal-title":"Emerg Infect Dis"},{"key":"key\n\t\t\t\t20170906122423_CIT0024","first-page":"20262","article-title":"Azole-resistant invasive aspergillosis in a patient with acute myeloid leukaemia in Germany","volume":"17","year":"2012","journal-title":"Euro Surveill"},{"key":"key\n\t\t\t\t20170906122423_CIT0025","doi-asserted-by":"crossref","first-page":"6060","DOI":"10.1128\/AAC.01017-12","article-title":"First reported case of azole-resistant Aspergillus fumigatus due to the TR\/L98H mutation in Germany","volume":"56","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170906122423_CIT0026","doi-asserted-by":"crossref","first-page":"832","DOI":"10.3201\/eid1905.130075","article-title":"Azole-resistant Aspergillus fumigatus, Iran","volume":"19","year":"2013","journal-title":"Emerg Infect Dis"},{"key":"key\n\t\t\t\t20170906122423_CIT0027","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1093\/jac\/dku566","article-title":"Emergence of azole-resistant invasive aspergillosis in HSCT recipients in Germany","volume":"70","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20170906122423_CIT0028","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1080\/13693780802545600","article-title":"Multiple-azole-resistant Aspergillus fumigatus osteomyelitis in a patient with chronic granulomatous disease successfully treated with long-term oral posaconazole and surgery","volume":"47","year":"2009","journal-title":"Med Mycol"},{"key":"key\n\t\t\t\t20170906122423_CIT0029","doi-asserted-by":"crossref","first-page":"156","DOI":"10.3201\/eid2201.150978","article-title":"Multiple fungicide-driven alterations in azole-resistant Aspergillus fumigatus, Colombia, 2015","volume":"22","year":"2016","journal-title":"Emerg Infect Dis"},{"key":"key\n\t\t\t\t20170906122423_CIT0030","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1128\/AAC.47.2.577-581.2003","article-title":"Mutations in Aspergillus fumigatus resulting in reduced susceptibility to posaconazole appear to be restricted to a single amino acid in the cytochrome P450 14\u03b1-demethylase","volume":"47","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170906122423_CIT0031","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1128\/AAC.48.7.2747-2750.2004","article-title":"Substitutions at methionine 220 in the 14\u03b1-sterol demethylase (Cyp51A) of Aspergillus fumigatus are responsible for resistance in vitro to azole antifungal drugs","volume":"48","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170906122423_CIT0032","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1093\/jac\/dkh507","article-title":"Mutations in the cyp51A gene and susceptibility to itraconazole in Aspergillus fumigatus serially isolated from a patient with lung aspergilloma","volume":"55","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20170906122423_CIT0033","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.ijantimicag.2006.08.017","article-title":"Multi-azole resistance in Aspergillus fumigatus","volume":"28","year":"2006","journal-title":"Int J Antimicrob Agents"},{"key":"key\n\t\t\t\t20170906122423_CIT0034","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.3201\/eid1507.090043","article-title":"Frequency and evolution of azole resistance in Aspergillus fumigatus associated with treatment failure","volume":"15","year":"2009","journal-title":"Emerg Infect Dis"},{"key":"key\n\t\t\t\t20170906122423_CIT0035","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3109\/13693780902717018","article-title":"Acquired resistance to voriconazole and itraconazole in a patient with pulmonary aspergilloma","volume":"48","year":"2010","journal-title":"Med Mycol"},{"key":"key\n\t\t\t\t20170906122423_CIT0036","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1128\/JCM.00329-12","article-title":"Resistance to voriconazole due to a G448S substitution in Aspergillus fumigatus in a patient with cerebral aspergillosis","volume":"50","year":"2012","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t20170906122423_CIT0037","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1128\/AAC.41.6.1364","article-title":"Itraconazole resistance in Aspergillus fumigatus","volume":"41","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170906122423_CIT0038","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1128\/AAC.47.3.1120-1124.2003","article-title":"A point mutation in the 14\u03b1-sterol demethylase gene cyp51A contributes to itraconazole resistance in Aspergillus fumigatus","volume":"47","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170906122423_CIT0039","doi-asserted-by":"crossref","first-page":"4870","DOI":"10.1128\/AAC.00514-12","article-title":"Correlation between triazole treatment history and susceptibility in clinically isolated Aspergillus fumigatus","volume":"56","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170906122423_CIT0040","doi-asserted-by":"crossref","first-page":"5113","DOI":"10.1128\/AAC.00517-11","article-title":"Interrogation of related clinical pan-azole-resistant Aspergillus fumigatus strains: G138C, Y431C, and G434C single nucleotide polymorphisms in cyp51A, upregulation of cyp51A, and integration and activation of transposon Atf1 in the cyp51A promoter","volume":"55","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170906122423_CIT0041","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1128\/AAC.00156-08","article-title":"Epidemiological cutoffs and cross-resistance to azole drugs in Aspergillus fumigatus","volume":"52","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170906122423_CIT0042","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1093\/jac\/dkq279","article-title":"Azole antifungal resistance in Aspergillus fumigatus: 2008 and 2009","volume":"65","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20170906122423_CIT0043","first-page":"428","article-title":"Prevalence and mechanism of triazole resistance in Aspergillus fumigatus in a referral chest hospital in Delhi, India and an update of the situation in Asia","volume":"6","year":"2015","journal-title":"Front Microbiol"},{"key":"key\n\t\t\t\t20170906122423_CIT0044","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1128\/AAC.05088-11","article-title":"Rapid induction of multiple resistance mechanisms in Aspergillus fumigatus during azole therapy: a case study and review of the literature","volume":"56","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170906122423_CIT0045","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jgar.2015.01.005","article-title":"Triazole-resistant Aspergillus fumigatus harbouring G54 mutation: is it de novo or environmentally acquired?","volume":"3","year":"2015","journal-title":"J Glob Antimicrob Resist"},{"key":"key\n\t\t\t\t20170906122423_CIT0046","doi-asserted-by":"crossref","first-page":"4356","DOI":"10.1128\/AAC.00100-15","article-title":"Environmental isolates of azole-resistant Aspergillus fumigatus in Germany","volume":"59","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170906122423_CIT0047","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1128\/AAC.01189-10","article-title":"Azole resistance of Aspergillus fumigatus biofilms is partly associated with efflux pump activity","volume":"55","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170906122423_CIT0048","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0378-1119(97)00281-3","article-title":"Genes encoding multiple drug resistance-like proteins in Aspergillus fumigatus and Aspergillus flavus","volume":"200","year":"1997","journal-title":"Gene"},{"key":"key\n\t\t\t\t20170906122423_CIT0049","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s00294-006-0073-2","article-title":"Transcriptome analysis of Aspergillus fumigatus exposed to voriconazole","volume":"50","year":"2006","journal-title":"Curr Genet"},{"key":"key\n\t\t\t\t20170906122423_CIT0050","first-page":"61:pii:e02748-16","article-title":"Contributions of both ATP-binding cassette transporter and Cyp51A proteins are essential for azole resistance in Aspergillus fumigatus","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170906122423_CIT0051","doi-asserted-by":"crossref","first-page":"e50034","DOI":"10.1371\/journal.pone.0050034","article-title":"Discovery of a hapE mutation that causes azole resistance in Aspergillus fumigatus through whole genome sequencing and sexual crossing","volume":"7","year":"2012","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20170906122423_CIT0052","doi-asserted-by":"crossref","first-page":"4202","DOI":"10.1128\/JCM.01105-14","article-title":"Whole-genome comparison of Aspergillus fumigatus strains serially isolated from patients with aspergillosis","volume":"52","year":"2014","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t20170906122423_CIT0053","doi-asserted-by":"crossref","first-page":"e02101-16","DOI":"10.1128\/AAC.02101-16","article-title":"Screening and characterization of the non-cyp51A mutation Afcox10 conferring azole resistance in Aspergillus fumigatus","volume":"61","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170906122423_CIT0054","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1128\/AAC.49.2.518-524.2005","article-title":"Cholesterol import by Aspergillus fumigatus and its influence on antifungal potency of sterol biosynthesis inhibitors","volume":"49","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170906122423_CIT0055","doi-asserted-by":"crossref","first-page":"e1000200","DOI":"10.1371\/journal.ppat.1000200","article-title":"A sterol-regulatory element binding protein is required for cell polarity, hypoxia adaptation, azole drug resistance, and virulence in Aspergillus fumigatus","volume":"4","year":"2008","journal-title":"PLoS Pathog"},{"key":"key\n\t\t\t\t20170906122423_CIT0056","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1093\/jac\/44.4.553","article-title":"In vitro susceptibility of Aspergillus spp. isolates to amphotericin B and itraconazole","volume":"44","year":"1999","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20170906122423_CIT0057","doi-asserted-by":"crossref","first-page":"3271","DOI":"10.1128\/JCM.00854-09","article-title":"Patterns of susceptibility of Aspergillus isolates recovered from patients enrolled in the Transplant-Associated Infection Surveillance Network","volume":"47","year":"2009","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t20170906122423_CIT0058","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s10156-010-0202-1","article-title":"Molecular typing and in-vitro activity of azoles against clinical isolates of Aspergillus fumigatus and A. niger in Japan","volume":"17","year":"2011","journal-title":"J Infect Chemother"},{"key":"key\n\t\t\t\t20170906122423_CIT0059","doi-asserted-by":"crossref","first-page":"3564","DOI":"10.1128\/AAC.01544-10","article-title":"Failure of posaconazole therapy in a renal transplant patient with invasive aspergillosis due to Aspergillus fumigatus with attenuated susceptibility to posaconazole","volume":"55","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170906122423_CIT0060","first-page":"46","article-title":"Invasive pulmonary aspergillosis due to a multi-azole resistant Aspergillus fumigatus","volume":"67","year":"2012","journal-title":"Acta Clin Belg"},{"key":"key\n\t\t\t\t20170906122423_CIT0061","first-page":"20326","article-title":"Azole-resistant Aspergillus fumigatus due to TR46\/Y121F\/T289A mutation emerging in Belgium, July 2012","volume":"17","year":"2012","journal-title":"Euro Surveill"},{"key":"key\n\t\t\t\t20170906122423_CIT0062","doi-asserted-by":"crossref","first-page":"5096","DOI":"10.1128\/AAC.02855-14","article-title":"First detection of TR46\/Y121F\/T289A and TR34\/L98H alterations in Aspergillus fumigatus isolates from azole-naive patients in Denmark despite negative findings in the environment","volume":"58","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170906122423_CIT0063","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1093\/jac\/dkr443","article-title":"Isolation of multiple-triazole-resistant Aspergillus fumigatus strains carrying the TR\/L98H mutations in the cyp51A gene in India","volume":"67","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20170906122423_CIT0064","doi-asserted-by":"crossref","first-page":"3439","DOI":"10.1093\/jac\/dku289","article-title":"New case of azole-resistant Aspergillus fumigatus due to TR46\/Y121F\/T289A mutation in Belgium","volume":"69","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20170906122423_CIT0065","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.1093\/jac\/dkv177","article-title":"High prevalence of azole resistance in Aspergillus fumigatus isolates from high-risk patients","volume":"70","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20170906122423_CIT0066","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.3201\/eid2106.140717","article-title":"Prospective multicenter international surveillance of azole resistance in Aspergillus fumigatus","volume":"21","year":"2015","journal-title":"Emerg Infect Dis"},{"key":"key\n\t\t\t\t20170906122423_CIT0067","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1111\/myc.12354","article-title":"Azole-resistant Aspergillus fumigatus isolates carrying TR\u2083\u2084\/L98H mutations in Taiwan","volume":"58","year":"2015","journal-title":"Mycoses"},{"key":"key\n\t\t\t\t20170906122423_CIT0068","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1093\/mmy\/myv029","article-title":"Prospective evaluation of azole resistance in Aspergillus fumigatus clinical isolates in France","volume":"53","year":"2015","journal-title":"Med Mycol"},{"key":"key\n\t\t\t\t20170906122423_CIT0069","doi-asserted-by":"crossref","first-page":"4331","DOI":"10.1128\/AAC.00127-15","article-title":"First description of azole-resistant Aspergillus fumigatus due to TR46\/Y121F\/T289A mutation in France","volume":"59","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170906122423_CIT0070","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1128\/JCM.02478-15","article-title":"First detection of TR34 L98H and TR46 Y121F T289A Cyp51 mutations in Aspergillus fumigatus isolates in the United States","volume":"54","year":"2016","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t20170906122423_CIT0071","doi-asserted-by":"crossref","first-page":"30300","DOI":"10.2807\/1560-7917.ES.2016.21.30.30300","article-title":"Emerging aspergillosis by azole-resistant Aspergillus fumigatus at an intensive care unit in the Netherlands, 2010 to 2013","volume":"21","year":"2016","journal-title":"Euro Surveill"},{"key":"key\n\t\t\t\t20170906122423_CIT0072","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.ijantimicag.2016.10.019","article-title":"Epidemiology of invasive aspergillosis and azole resistance in patients with acute leukaemia: the SEPIA Study","volume":"49","year":"2017","journal-title":"Int J Antimicrob Agents"},{"key":"key\n\t\t\t\t20170906122423_CIT0073","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1128\/AAC.01130-15","article-title":"Molecular characterization of a voriconazole- resistant, posaconazole-susceptible Aspergillus fumigatus isolate in a lung transplant recipient in the United States","volume":"60","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170906122423_CIT0074","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1093\/cid\/ciw664","article-title":"Home environment as a source of life-threatening azole-resistant Aspergillus fumigatus in immunocompromised patients","volume":"64","year":"2017","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170906122423_CIT0075","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1186\/s12879-016-1796-4","article-title":"Aspergillus fumigatus carrying TR34\/L98H resistance allele causing complicated suppurative otitis media in Tanzania: call for improved diagnosis of fungi in sub-Saharan Africa","volume":"16","year":"2016","journal-title":"BMC Infect Dis"},{"key":"key\n\t\t\t\t20170906122423_CIT0076","doi-asserted-by":"crossref","first-page":"570.e1","DOI":"10.1016\/j.cmi.2016.04.001","article-title":"Azole-resistant Aspergillus fumigatus in Denmark: a laboratory-based study on resistance mechanisms and genotypes","volume":"22","year":"2016","journal-title":"Clin Microbiol Infect"},{"key":"key\n\t\t\t\t20170906122423_CIT0077","article-title":"Changes in in vitro susceptibility patterns of Aspergillus to triazoles and correlation with aspergillosis outcome in a tertiary care center, 1999\u20132015","year":"2017","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170906122423_CIT0078","doi-asserted-by":"crossref","first-page":"5438","DOI":"10.1128\/AAC.00833-13","article-title":"Impact of in vivo triazole and echinocandin combination therapy for invasive pulmonary aspergillosis: enhanced efficacy against Cyp51 mutant isolates","volume":"57","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170906122423_CIT0079","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1093\/jac\/dku364","article-title":"Azole, polyene and echinocandin MIC distributions for wild-type, TR34\/L98H and TR46\/Y121F\/T289A Aspergillus fumigatus isolates in the Netherlands","volume":"70","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20170906122423_CIT0080","doi-asserted-by":"crossref","first-page":"5426","DOI":"10.1128\/AAC.01111-13","article-title":"Determination of isavuconazole susceptibility of Aspergillus and Candida species by the EUCAST method","volume":"57","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170906122423_CIT0081","doi-asserted-by":"crossref","first-page":"5778","DOI":"10.1128\/AAC.01141-13","article-title":"In vitro susceptibility of Aspergillus fumigatus to isavuconazole: correlation with itraconazole, voriconazole, and posaconazole","volume":"57","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170906122423_CIT0082","doi-asserted-by":"crossref","first-page":"6284","DOI":"10.1128\/AAC.01355-13","article-title":"Isavuconazole (BAL4815) pharmacodynamic target determination in an in vivo murine model of invasive pulmonary aspergillosis against wild-type and cyp51 mutant isolates of Aspergillus fumigatus","volume":"57","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170906122423_CIT0083","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.1128\/AAC.04907-14","article-title":"Pharmacodynamics of isavuconazole in an Aspergillus fumigatus mouse infection model","volume":"59","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170906122423_CIT0084","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1128\/JCM.00213-11","article-title":"Aspergillus species and other molds in respiratory samples from patients with cystic fibrosis: a laboratory-based study with focus on Aspergillus fumigatus azole resistance","volume":"49","year":"2011","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t20170906122423_CIT0085","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.1128\/AAC.01358-10","article-title":"Aspergillus fumigatus strains with mutations in the cyp51A gene do not always show phenotypic resistance to itraconazole, voriconazole, or posaconazole","volume":"55","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170906122423_CIT0086","doi-asserted-by":"crossref","first-page":"3380","DOI":"10.1128\/AAC.00383-13","article-title":"Population-based survey of filamentous fungi and antifungal resistance in Spain (FILPOP Study)","volume":"57","author":"FILPOP Study Group","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170906122423_CIT0087","doi-asserted-by":"crossref","first-page":"837","DOI":"10.18388\/abp.2015_1143","article-title":"Examination of cyp51A and cyp51B expression level of the first Polish azole resistant clinical Aspergillus fumigatus isolate","volume":"62","year":"2015","journal-title":"Acta Biochim Pol"},{"key":"key\n\t\t\t\t20170906122423_CIT0088","first-page":"682","article-title":"Azole resistance in Aspergillus fumigatus clinical isolates from an Italian culture collection","volume":"60","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170906122423_CIT0089","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.nmni.2015.04.005","article-title":"First detection of Aspergillus fumigatus azole-resistant strain due to Cyp51A TR46\/Y121F\/T289A in an azole-naive patient in Spain","volume":"6","year":"2015","journal-title":"New Microbes New Infect"},{"key":"key\n\t\t\t\t20170906122423_CIT0090","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jcf.2016.06.006","article-title":"Triazole resistance in Aspergillus fumigatus isolates from patients with cystic fibrosis in Italy","volume":"16","year":"2017","journal-title":"J Cyst Fibros"},{"key":"key\n\t\t\t\t20170906122423_CIT0091","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.jiac.2015.04.012","article-title":"First determination of azole resistance in Aspergillus fumigatus strains carrying the TR34\/L98H mutations in Turkey","volume":"21","year":"2015","journal-title":"J Infect Chemother"},{"key":"key\n\t\t\t\t20170906122423_CIT0092","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1093\/jac\/dkq450","article-title":"Low prevalence of resistance to azoles in Aspergillus fumigatus in a French cohort of patients treated for haematological malignancies","volume":"66","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20170906122423_CIT0093","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1128\/AAC.05077-11","article-title":"High prevalence of azole- resistant Aspergillus fumigatus in adults with cystic fibrosis exposed to itraconazole","volume":"56","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170906122423_CIT0094","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1093\/jac\/dks160","article-title":"High prevalence of triazole resistance in Aspergillus fumigatus, especially mediated by TR\/L98H, in a French cohort of patients with cystic fibrosis","volume":"67","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20170906122423_CIT0095","doi-asserted-by":"crossref","first-page":"3513","DOI":"10.1128\/AAC.00167-13","article-title":"cyp51A-Based mechanisms of Aspergillus fumigatus azole drug resistance present in clinical samples from Germany","volume":"57","author":"MykoLabNet-D Partners","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170906122423_CIT0096","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1128\/AAC.49.2.512-517.2005","article-title":"Antifungal susceptibilities of clinical isolates of Candida species, Cryptococcus neoformans, and Aspergillus species from Taiwan: Surveillance of multicenter antimicrobial resistance in Taiwan program data from 2003","volume":"49","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170906122423_CIT0097","doi-asserted-by":"crossref","first-page":"4465","DOI":"10.1128\/AAC.00185-11","article-title":"Azole resistance in Aspergillus fumigatus isolates from the ARTEMIS global surveillance study is primarily due to the TR\/L98H mutation in the cyp51A gene","volume":"55","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170906122423_CIT0098","unstructured":"Perveen I , SeharS, NazI, AhmedS. Prospective evaluation of azole resistance in Aspergillus fumigatus clinical isolates in Pakistan. In: Proceedings of Seventh Advances Against Aspergillosis conference;3\u20135 March 2016; Manchester, UK."},{"key":"key\n\t\t\t\t20170906122423_CIT0099","article-title":"First clinical isolation report of azole- resistant Aspergillus fumigatus with TR34\/L98H-type mutation in Japan","year":"2017","journal-title":"J Infect Chemother"},{"key":"key\n\t\t\t\t20170906122423_CIT0100","unstructured":"Toyotome T , FujiwaraT, KidaH, MatsumotoM, WadaT, KomatsuR. Susceptibility to azoles in clinical isolates of Aspergillus fumigatus and A. tubingensis from Obihiro, Japan. In: Proceedings of Seventh Advances Against Aspergillosis conference; 3\u20135 March 2016; Manchester, UK."},{"key":"key\n\t\t\t\t20170906122423_CIT0101","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.jiac.2016.01.015","article-title":"Multi-azole resistant Aspergillus fumigatus harboring Cyp51A TR46\/Y121F\/T289A isolated in Japan","volume":"22","year":"2016","journal-title":"J Infect Chemother"},{"key":"key\n\t\t\t\t20170906122423_CIT0102","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1093\/jac\/dku410","article-title":"Concomitant occurrence of itraconazole-resistant and -susceptible strains of Aspergillus fumigatus in routine cultures","volume":"70","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20170906122423_CIT0103","first-page":"387","article-title":"Quantitative analysis of single- nucleotide polymorphism for rapid detection of TR34\/L98H- and TR46\/Y121F\/T289A-positive Aspergillus fumigatus isolates obtained from patients in Iran from 2010 to 2014","volume":"60","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170906122423_CIT0104","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.3201\/eid2009.140142","article-title":"Passive surveillance for azole-resistant Aspergillus fumigatus, United States, 2011\u20132013","volume":"20","year":"2014","journal-title":"Emerg Infect Dis"},{"key":"key\n\t\t\t\t20170906122423_CIT0105","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3390\/jof3010005","article-title":"Global aspects of triazole resistance in Aspergillus fumigatus with focus on Latin American countries","volume":"3","year":"2017","journal-title":"J Fungi"},{"key":"key\n\t\t\t\t20170906122423_CIT0106","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/myc.12324","article-title":"Multi-triazole-resistant Aspergillus fumigatus infections in Australia","volume":"58","year":"2015","journal-title":"Mycoses"},{"key":"key\n\t\t\t\t20170906122423_CIT0107","doi-asserted-by":"crossref","first-page":"20150460","DOI":"10.1098\/rstb.2015.0460","article-title":"Clinical implications of globally emerging azole resistance in Aspergillus fumigatus","volume":"371","year":"2016","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"key\n\t\t\t\t20170906122423_CIT0108","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/ciw326","article-title":"Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the Infectious Diseases Society of America","volume":"63","year":"2016","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170906122423_CIT0109","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1093\/jac\/dkw259","article-title":"Azole resistance surveillance in Aspergillus fumigatus: beneficial or biased?","volume":"71","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20170906122423_CIT0110","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1093\/jac\/dkw036","article-title":"New therapeutic strategies for invasive aspergillosis in the era of azole resistance: how should the prevalence of azole resistance be defined?","volume":"71","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20170906122423_CIT0111","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/myc.12440","article-title":"Diagnosis and management of aspergillosis in the Netherlands: a national survey","volume":"59","year":"2016","journal-title":"Mycoses"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jid\/article-pdf\/216\/suppl_3\/S436\/19708770\/jix210.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,22]],"date-time":"2019-09-22T19:54:02Z","timestamp":1569182042000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/jid\/article\/216\/suppl_3\/S436\/4107054\/AzoleResistant-Aspergillosis-Epidemiology"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,15]]},"references-count":111,"journal-issue":{"issue":"suppl_3","published-online":{"date-parts":[[2017,9,5]]},"published-print":{"date-parts":[[2017,8,15]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jix210","relation":{},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"value":"0022-1899","type":"print"},{"value":"1537-6613","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,15]]}}}